Propeller Health
Propeller Health provides Bluetooth-enabled smart inhaler sensors, mobile applications, and cloud analytics for medication adherence and respiratory disease management, serving asthma and COPD patients through healthcare providers, payers, and pharmaceutical partners as a ResMed subsidiary.
- Company typePrivate
- Founded2012
- HeadquartersMadison, United States
- Headcount51–100
- GTM typeB2B
- OfferingSoftware
What Propeller Health does
Propeller Health is a digital health platform that provides Bluetooth-enabled smart inhaler sensors, companion mobile applications, and cloud-based analytics to support medication adherence and respiratory disease management for patients with asthma and COPD. The core technology consists of sensors that attach to standard inhalers and automatically capture medication usage, timing, and location data, transmitting it to a mobile app and cloud backend where it is processed to generate personalized feedback, trigger identification, and clinical decision support. The platform is FDA-cleared and supported by peer-reviewed clinical evidence, including an AIR Louisville study published in Health Affairs demonstrating measurable reduction in rescue inhaler use at one year on the platform.
Founded in 2012 in Madison, Wisconsin, Propeller Health was acquired by ResMed (NYSE: RMD) in 2019 and operates as a wholly-owned subsidiary within ResMed's digital health portfolio. The business generates revenue through connected device hardware sales to healthcare providers and patients, subscription-based remote patient monitoring SaaS contracts with health systems and payers, and pharmaceutical partnership arrangements positioned as "beyond-the-pill" digital companion solutions. Distribution is executed through ResMed's enterprise field sales organization, pharmaceutical company partnerships, and payer/PBM networks across the Americas, Europe, and Asia Pacific, rather than through direct-to-consumer channels. The platform is integrated with ResMed's AirView remote monitoring cloud, enabling clinicians to consolidate respiratory medication adherence data alongside sleep and ventilation metrics from ResMed's broader connected care portfolio.
Propeller Health is identified as a key player in the connected drug delivery devices market, which is forecast to grow from $986.91 million in 2024 to $5.08 billion by 2032 at a 23.17% CAGR. The company competes in a market alongside Adherium, Teva Pharmaceuticals, and COHERO Health, and benefits from ResMed's parent-company infrastructure spanning 126+ million lives and 15+ million cloud-connectable devices. Leadership includes co-founder and CTO Greg Tracy, Chief Commercial Officer Chris Hogg, and senior executives covering business development, clinical and medical affairs, finance, and product. Revenue is not separately disclosed because Propeller's financials are consolidated within ResMed's reported figures.
Propeller Health firmographics
Firmographics- Name
- Propeller Health
- Legal name
- Propeller Health
- Website
- https://propellerhealth.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Propeller Health provides Bluetooth-enabled smart inhaler sensors, mobile applications, and cloud analytics for medication adherence and respiratory disease management, serving asthma and COPD patients through healthcare providers, payers, and pharmaceutical partners as a ResMed subsidiary.
- Ownership category
- akta.pro rank
Propeller Health industry classification
Industry- Product category
- Digital Respiratory Health / Connected Inhaler Platform
- NAICS
- Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing (333413)
- SIC
- Industrial & Commercial Fans & Blowers & Air Purifing Equip (3564)
- akta.pro primary industry
- Nebulizers & Aerosol Drug Delivery Systems (HLAHAIAJ)
- akta.pro secondary industry
- Asthma & Airway Disease Specialty Care (HLAKAAAC)
Keywords
Where Propeller Health is headquartered
LocationHeadquarters
- HQ city
- Madison
- HQ country
- United States
- HQ region
- North America
Markets served
Propeller Health business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
Revenue model
- Connected Device Hardware Sales: Sale of smart inhaler sensors and connected devices to healthcare providers, health systems, and patients. Sensors attach to standard inhalers enabling medication tracking functionality.
- Software as a Service (SaaS) / Remote Patient Monitoring: Subscription-based software services for healthcare providers enabling remote monitoring of patient medication adherence and respiratory outcomes. Revenue generated through enterprise agreements with health systems, payers, and provider networks.
- Pharmaceutical Partnerships: Partnership arrangements with pharmaceutical companies for co-development of medication adherence solutions and integration with respiratory drug therapies, potentially including licensing and collaborative development arrangements.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Propeller Health product offering
Product offeringCore offering
Propeller Health operates a connected inhaler platform for asthma and COPD management. It sells Bluetooth-enabled medication sensors that attach to standard inhalers, companion iOS and Android mobile applications, and cloud-based analytics delivered to healthcare providers for remote patient monitoring. The platform is distributed primarily through ResMed's enterprise healthcare professional sales organization and pharmaceutical partnerships.
Product overview
Propeller Health is a digital therapeutics platform focused on respiratory care, specifically smart inhaler technology for asthma and COPD management. The platform consists of a connected sensor device that attaches to inhalers, a mobile application, and cloud-based analytics. As a ResMed subsidiary, Propeller Health operates as part of ResMed's broader digital health ecosystem alongside solutions like AirView for sleep and respiratory care monitoring.
Differentiator
Problem solved
Functional benefit
Products and services
- Propeller Health Connected Inhaler Platform Digital health platform for respiratory care combining Bluetooth-enabled inhaler sensors, companion mobile applications, and cloud-based analytics to track medication usage, support asthma and COPD management, and reduce rescue inhaler use through data-driven patient engagement. Targeted at healthcare providers, health systems, payers, and pharmaceutical partners via ResMed's distribution network.
Quantifiable outcome
- Average reduction in rescue inhaler use at one year on Propeller platform
Companies that use Propeller Health
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
Propeller Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Propeller Health partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- ResMedcorePropeller Health was acquired by ResMed (2019) and operates as a wholly-owned subsidiary within ResMed's digital health portfolio. The platform is integrated with ResMed's AirView remote monitoring platform and distributed through ResMed's healthcare professional sales network. Propeller Health benefits from ResMed's global distribution infrastructure, R&D resources, and established relationships with healthcare providers and payers in the sleep and respiratory care markets.
Scale indicators4 records
Recent moves5 records
Expansion highlights5 records
Propeller Health competitors and assessment
Company assessmentDirect peers
- Adherium: Adherium develops connected inhaler sensors and digital respiratory health platforms, directly competing with Propeller Health in smart inhaler technology for asthma and COPD. Both attach sensors to standard inhalers and provide adherence analytics to patients, providers, and pharma partners.
- COHERO Health: COHERO Health offers connected inhaler technology and respiratory disease management platforms, including smart spacers and mobile apps. Like Propeller, it targets healthcare providers and patients with asthma and COPD for adherence tracking and remote monitoring.
Broad incumbents
- Teva Pharmaceutical Industries: Teva is a major respiratory drug manufacturer (ProAir Digihaler) and has been identified alongside Propeller as a key player in connected drug delivery. Teva integrates sensors directly into its inhalers, representing a vertically integrated competitor with first-party digital companions.
- GlaxoSmithKline (GSK): GSK manufactures leading respiratory inhalers (Ellipta, Trelegy) and has invested in digital respiratory solutions and sensor-equipped devices. As a major pharma player in asthma and COPD, GSK competes with Propeller as both a partner and a first-party digital therapeutics developer.
- AstraZeneca: AstraZeneca markets major respiratory brands (Symbicort, Fasenra) and has explored digital inhaler companions and partnerships. Its scale in respiratory therapeutics makes it both a potential channel partner and a competitive threat to Propeller's pharma partnership model.
- Boehringer Ingelheim: Boehringer Ingelheim produces the Respimat inhaler and has invested in digital health initiatives for COPD and asthma. Like other big respiratory pharmas, it is both a potential partner and an integrated competitor in connected respiratory care.
- ResMed: ResMed is Propeller Health's parent company and a leading manufacturer of CPAP and ventilation devices with AirView and myAir platforms. The strategic overlap in remote respiratory monitoring makes ResMed both the primary distribution channel and a strategic comparator for connected respiratory care solutions.
- Philips Respiratory Care: Philips offers connected respiratory care solutions including ventilators, CPAP, and remote patient monitoring through its Care Orchestrator platform. While primarily focused on sleep and hospital ventilation, Philips' connected respiratory ecosystem overlaps with Propeller's provider-facing RPM positioning.
Others
- AptarGroup: AptarGroup is a leading manufacturer of inhaler components and drug delivery devices, and was a lead investor in Propeller's Series C. Aptar provides enabling hardware technology across the respiratory value chain and serves as both an investor/partner and adjacent industry player.
Emerging players
- Voluntis: Voluntis (now part of Insulet) develops digital therapeutics platforms for chronic conditions including respiratory disease. Its Theraxium platform provides connected software-based therapy management, representing an emerging digital-only competitor to Propeller's sensor-plus-software model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Propeller Health social profiles
Digital presencePropeller Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Propeller Health leadership team
Management profileNumber of profiles
Profiles6 records
Propeller Health funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Propeller Health M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Propeller Health
What does Propeller Health do?
Propeller Health operates a connected inhaler platform for asthma and COPD management. It sells Bluetooth-enabled medication sensors that attach to standard inhalers, companion iOS and Android mobile applications, and cloud-based analytics delivered to healthcare providers for remote patient monitoring. The platform is distributed primarily through ResMed's enterprise healthcare professional sales organization and pharmaceutical partnerships.
Is Propeller Health a public or private company?
Propeller Health is a private company. It is classified as corporate owned and is currently operating.
When was Propeller Health founded?
Propeller Health was founded in 2012. It employs 51 to 100 people.
Where is Propeller Health based?
Propeller Health is headquartered in Madison, United States, in the North America region.
How does Propeller Health make money?
Three revenue lines are on record. Connected Device Hardware Sales are the primary driver. The others are software as a Service (SaaS) / Remote Patient Monitoring and pharmaceutical Partnerships.
Who are Propeller Health's main competitors?
Direct peers on record are Adherium and COHERO Health. Broad incumbents are Teva Pharmaceutical Industries, GlaxoSmithKline (GSK), AstraZeneca, Boehringer Ingelheim, ResMed and Philips Respiratory Care. AptarGroup is listed as an others. Voluntis is listed as an emerging player.
Does Propeller Health have an API?
No public API is recorded for Propeller Health.
What industry is Propeller Health in?
Propeller Health's product category is Digital Respiratory Health / Connected Inhaler Platform. Its primary akta.pro industry code is HLAHAIAJ, Nebulizers & Aerosol Drug Delivery Systems, with a secondary code of HLAKAAAC, Asthma & Airway Disease Specialty Care. Its NAICS code is 333413 and its SIC code is 3564.